The Synthetic Cannabinoid R(+)WIN 55,212-2 Inhibits the Interleukin-1 Signaling Pathway in Human Astrocytes in a Cannabinoid Receptor-independent Manner

This publication has 30 references indexed in Scilit:

• Induction of chemokines in human astrocytes by picornavirus infection requires activation of both AP‐1 and NF‐κB
  Glia, 2003
• Endothelin‐1 increases 2‐arachidonoyl glycerol (2‐AG) production in astrocytes
  Glia, 2003
• Anandamide Inhibits Nuclear Factor-κB Activation through a Cannabinoid Receptor-Independent Pathway
  Molecular Pharmacology, 2003
• p38-dependent marking of inflammatory genes for increased NF-κB recruitment
  Nature Immunology, 2001
• Interleukin 1 in the brain: biology, pathology and therapeutic target
  Trends in Neurosciences, 2000
• Analyzer Workshop on the Treatment of Parkinson's Disease
  European Neurology, 1997
• Expression of Central and Peripheral Cannabinoid Receptors in Human Immune Tissues and Leukocyte Subpopulations
  European Journal of Biochemistry, 1995
• Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrin
  Nature, 1992
• Delta-9-THC in the Treatment of Spasticity Associated with Multiple Sclerosis
  Advances in Alcohol & Substance Abuse, 1988
• T Cells in Multiple Sclerosis and Inflammatory Central Nervous System Diseases
  Immunological Reviews, 1987